Nervous Disorder TRIZ Cases

A uridine source combined with omega-3 polyunsaturated fatty acids enhances neurological functioning to improve limb motor capabilities.

Targeted protease cleaves SNARE proteins to halt hormone secretion, avoiding surgical risks and tumor lysis syndrome.

Allele-specific siRNA sequences target mutated huntingtin mRNA for degradation via RNA interference mechanisms.

Engineered synthetic immune receptors employ TCR constant chain mutations to extend lymphocyte persistence while preventing cytokine release syndrome.

Parallel silk fibroin elements inside a resorbable tubular body guide axon growth, preventing scar tissue formation and neuroma development.

Segmenting the molecule resolves binding affinity versus tumor permeability contradictions while enhancing retention.

An impermeable backing film overlaps the active substance matrix edges to prevent cold-flow leakage and maintain storage stability.

Specific amino acid substitutions in modified AAV capsid proteins evade neutralizing antibodies, enabling repeat gene therapy administrations.

Exosome-based therapy resolves product consistency issues in cell therapies by extracting regenerative factors from immortalized donor banks.

Multivalent single-chain binding proteins link variable regions to constant domains via a scorpion linker for localized effector functions.

Transgenic neural precursor cells cross the blood-brain barrier to deliver functional cell replacement therapy.

A 24-amino acid MANS peptide blocks MARCKS protein binding to phospholipids.

Engrailed homeoprotein restores heterochromatin marks and activates anti-apoptotic pathways to protect cells from DNA damage.

Linear or stepped gradient elution resolves glatiramer acetate components that single methods cannot distinguish, ensuring accurate content analysis.

Engineered recombinant gelatins with defined ERGD spacing resolve stability and yield trade-offs to improve cell adhesion in culture systems.

Perlecan domain V binds alpha2beta1 integrin, blocking amyloid beta deposition and toxicity in neuronal cells.

Controlled-release aminopyridine formulation segments dosing via diffusion to flatten plasma peaks and reduce adverse side effects.

A composition of uridine phosphate and docosahexaenoic acid administered enterally improves memory function in subjects with mild cognitive impairment.

Metallic grains in a patch compress indurations to convert bioelectric potential, reducing healing time.

Transplanted pluripotent stem cells generate dopamine-producing neurons, countering progressive neuronal loss in neurodegenerative disorders.

Metallocene compounds treat drug-resistant tumors by inhibiting cancer cell viability while minimizing toxicity to healthy cells.

Polyglycerol esters of 3-hydroxybutyric acid provide a stable prodrug form that releases active ketone bodies through enzymatic hydrolysis.

Oral gamma-hydroxybutyrate salts address underlying cognitive processing difficulties in dyslexia where behavioral interventions lack medical efficacy.

Monoclonal antibodies bind tau epitopes to induce phagocytic clearance of pathological protein aggregates.

Engineered recombinant hemoglobins utilize temperature-sensitive instability to precipitate impurities during controlled cooling.

Csnk2 inhibitors restore diurnal rhythmicity of the gut microbiota, preventing dysbiosis and chronic inflammatory diseases caused by circadian clock disruption.

Optimized administration rates and volumes reduce back pain and cell clumping while enabling higher therapeutic dosages.

A DYRK1A inhibitor compound stabilizes cyclin D1 to promote neural stem cell proliferation.

Constitutively active STEP-derived peptides cross the blood-brain barrier to provide neuroprotection.

Formula I compounds target M1 receptors with high selectivity, resolving the trade-off between therapeutic efficacy and receptor specificity.

Delivering CYP46A1 via viral vectors degrades excess cholesterol in striatal neurons, reducing aggregate formation and slowing Huntington's disease progression.

Anti-human CCR4 antibody reduces HTLV-1 infected cells and proviral DNA, addressing adverse events from broad immunosuppression.

Specific embryonic stem cell microRNAs enhance somatic cell reprogramming into induced pluripotent stem cells without viral vectors.

Segmented immediate and sustained-release granules maintain stable plasma concentrations, reducing side effects from rapid absorption fluctuations.

Compressed transparent elastomer seals optical fiber against sapphire window, reducing reflection losses and preventing physiological fluid contamination.

Triazole carbamate pyridyl sulfonamides bind LPAR1 receptors, balancing selectivity and metabolic stability to treat fibrosis.

Polyethylene glycol shielding blocks proteolytic enzymes to enhance stability while reducing immunogenicity in protein therapeutics.

pH-dependent polypeptides increase activity in acidic tumor microenvironments while remaining inactive at neutral physiological pH, reducing side effects.

Pre-beta HDL particles drain amyloid beta peptides from blood, addressing inefficient apheresis removal of cerebral amyloid angiopathy markers.

Administering activated ILC2s suppresses neuroinflammation and stabilizes the blood-brain barrier to resolve off-target effects from current therapies.

A pegylated growth hormone receptor antagonist conjugates a 40 kDa branched polyethylene glycol molecule to a substituted cysteine residue.

Gene therapy delivers engineered chimeric receptors to neurons, enabling non-invasive pain relief without opioid addiction risks.

Selecting calgG-A or calgG-D isotypes prevents harmful immune-mediated damage while maintaining therapeutic efficacy against canine cancer and pain.

IGF-2 administration reduces seizure severity and frequency in Angelman Syndrome, addressing ineffective conventional treatments.

Fusing TRAIL to immunoglobulin constant regions extends serum half-life and enables blood-brain barrier penetration for brain tumor treatment.

Self-assembling sarcosine-hydroxy acid copolymers form micelles that reduce skin irritation while improving drug permeability.